|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 61 | 2018 | Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe | Fraser, Hannah; Martin, Natasha K.; Brummer-Korvenkontio, Henrikki; Carrieri, Patrizia; Dalgard, Olav; Dillon, John; Goldberg, David; Hutchinson, Sharon; Jauffret-Roustide, Marie; Kaberg, Martin; Matser, Amy A.; Maticic, Mojca; Midgard, Havard; Mravcik, Viktor; Ovrehus, Anne; Prins, Maria; Reimer, Jens; ROBAEYS, Geert; Schulte, Bernd; van Santen, Daniela K.; Zimmermann, Ruth; Vickerman, Peter; Hickman, Matthew | Journal Contribution | A1 |
| 62 | 2018 | Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes | Van Hees, S.; Bourgeois, S.; Van Vlierberghe, Hans; Serste, T.; Francque, S.; Michielsen, P.; Sprengers, D.; Reynaert, H.; Henrion, J.; Dastis, S. Negrin; Delwaide, J.; Lasser, L.; Decaestecker, J.; Orlent, H.; Janssens, F.; ROBAEYS, Geert; Colle, I.; Starkel, P.; Moreno, C.; Nevens, F.; Vanwolleghem, T. | Journal Contribution | A1 |
| 63 | 2018 | Horizontal hepatitis B virus transmission through non-sexual close contact in Turkish chronic hepatitis B patients living outside of Turkey. | KOC, Ozgur; ROBAEYS, Geert; Yildirim, B.; Posthouwer, D.; HENS, Niel; Koek, GH. | Journal Contribution | A1 |
| 64 | 2018 | Harm reduction and viral hepatitis C in European prisons: inadequate prevention measures in 25 European countries | BIELEN, Rob; Stumo, S. R.; Safreed-Harmon, K.; Halford, R.; Werling, K.; Reic, T.; Stoever, H.; ROBAEYS, Geert; Lazarus, J. V. | Journal Contribution | M |
| 65 | 2018 | Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries | BIELEN, Rob; Stumo, Samya R.; Halford, Rachel; Werling, Klara; Reic, Tatjana; Stoever, Heino; ROBAEYS, Geert; Lazarus, Jeffrey V. | Journal Contribution | A1 |
| 66 | 2018 | An adult patient with alcoholic liver cirrhosis and IgA vasculitis | Barrios, Leticia; ROBAEYS, Geert | Journal Contribution | A1 |
| 67 | 2018 | The burden of viral hepatitis C in key subgroups in Belgium: targets for micro-elimination | BIELEN, Rob; Salomonsson, S.; Toghanian, S.; VENKEN, Koen; Hiver, M.; Matthys, A.; Hendrickx, G.; Jadoul, M.; Nevens, F.; ROBAEYS, Geert; Lazarus, J. V. | Journal Contribution | M |
| 68 | 2018 | Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogs for patients at risk of renal failure after liver transplantation: a prospective single center cohort study | BIELEN, Rob; ROBAEYS, Geert; Schelfhout, Sigrid; Monbaliu, Diethard; Van der Merwe, Schalk; Pirenne, Jacques; Nevens, Frederik | Journal Contribution | A1 |
| 69 | 2018 | Pneumomediastinum as a complication of esophageal intramural pseudodiverticulosis | Struyve, M.; Langmans, C.; ROBAEYS, Geert | Journal Contribution | A1 |
| 70 | 2018 | Screening for hepatitis C at the emergency department: Babyboomers should also be screened in Belgium | BIELEN, Rob; KREMER, Cécile; KOC, Ozgur; HENDRICKX, Diana; VANELDEREN, Pascal; HENS, Niel; Nevens, F.; ROBAEYS, Geert | Journal Contribution | M |
| 71 | 2018 | The Prevalence and Risk Factors of Hepatitis B Viral Infection in Middle Limburg Belgium: The Importance of Migration. | KOC, Ozgur; KREMER, Cécile; BIELEN, Rob; BUSSCHOTS, Dana; HENS, Niel; ROBAEYS, Geert | Journal Contribution | M |
| 72 | 2018 | Screening for hepatitis C at the emergency department: Should babyboomers also be screened in Belgium? | BIELEN, Rob; KREMER, Cécile; KOC, Ozgur; BUSSCHOTS, Dana; HENDRICKX, Diana; VANELDEREN, Pascal; HENS, Niel; Nevens, Frederik; ROBAEYS, Geert | Journal Contribution | A1 |
| 73 | 2017 | Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues is highly effective and reduces cost for hepatitis B prophylaxis after liver transplantation | BIELEN, Rob; ROBAEYS, Geert; Schelfhout, S.; Monbaliu, D.; Van der Merwe, S.; Pirenne, J.; Nevens, F. | Journal Contribution | M |
| 74 | 2017 | Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe | Marshall, A. D.; Nielsen, S.; Cunningham, E. B.; Aghemo, A.; Alho, H.; Backmund, M.; Bruggmann, P.; Dalgard, O.; Flisiak, R.; Foster, G.; Gheorghe, L.; Goldberg, D.; Goulis, I.; Hickman, M.; Hoffmann, P.; Jancoriene, L.; Jarcuska, P.; Kaberg, M.; Makara, M.; Maimets, M.; Marinho, R.; Maticic, M.; Norris, S.; Olafsson, S.; Ovrehus, A.; Pawlotsky, J. -M.; Pocock, J.; ROBAEYS, Geert; Roncero, C.; Simonova, M.; Sperl, J.; Tait, M.; Tolmane, I.; Tomaselli, S.; van der Valk, M.; Vince, A.; Dore, G. J.; Lazarus, J. V.; Grebely, J. | Journal Contribution | M |
| 75 | 2017 | Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study | Grebely, Jason; Dalgard, Olav; Cunningham, Evan B.; Hajarizadeh, Behzad; Foster, Graham R.; Bruggmann, Philip; Conway, Brian; Backmund, Markus; ROBAEYS, Geert; Swan, Tracy; Amin, Janaki; Marks, Philippa S.; Quiene, Sophie; Applegate, Tanya L.; Weltman, Martin; Shaw, David; Dunlop, Adrian; Hellard, Margaret; Bruneau, Julie; Midgard, Havard; Bourgeois, Stefan; Staehelin, Cornelia; Dore, Gregory J. | Journal Contribution | A1 |
| 76 | 2017 | Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs | Grebely, Jason; Bruneau, Julie; Lazarus, Jeffrey V.; Dalgard, Olav; Bruggmann, Philip; Treloar, Carla; Hickman, Matthew; Hellard, Margaret; Roberts, Teri; Crooks, Levinia; Midgard, Havard; Larney, Sarah; Degenhardt, Louisa; Alho, Hannu; Byrne, Jude; Dillon, John F.; Feld, Jordan J.; Foster, Graham; Goldberg, David; Lloyd, Andrew R.; Reimer, Jens; ROBAEYS, Geert; Torrens, Marta; Wright, Nat; Maremmani, Icro; Norton, Brianna L.; Litwin, Alain H.; Dore, Gregory J. | Journal Contribution | A1 |
| 77 | 2017 | Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study | Midgard, Havard; Hajarizadeh, Behzad; Cunningham, Evan B.; Conway, Brian; Backmund, Markus; Bruggmann, Philip; Bruneau, Julie; Bourgeois, Stefan; Dunlop, Adrian; Foster, Graham R.; Hellard, Margaret; ROBAEYS, Geert; Thurnheer, Maria C.; Weltman, Martin; Amin, Janaki; Marks, Philippa S.; Quiene, Sophie; Dore, Gregory J.; Dalgard, Olav; Grebely, Jason | Journal Contribution | A1 |
| 78 | 2017 | Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues is highly effective and reduces cost for hepatitis B prophylaxis after liver transplantation | BIELEN, Rob; ROBAEYS, Geert; Schelfhout, S.; Monbaliu, D.; Van Der Merwe, S.; Pirenne, J. | Conference Material | C2 |
| 79 | 2017 | Cessation of Nucleos(t)ide Analogue treatment after HBeAg seroconversion is associated with a 4-fold increased risk of relapse in cirrhotic compared to non-cirrhotic patients | Van Hees, Stijn; Bourgeois, Stefan; Van Vlierberghe, Hans; Serste, Thomas; Francque, Sven; Michielsen, Peter P.; Dirk, Sprengers; Reynaert, Hendrik; Henrion, Jean; Dastis, Sergio Negrin; Delwaide, Jean; Lasser, Luc; Decaestecker, Jochen; Orient, Hans; Janssens, Filip; ROBAEYS, Geert; Colle, Isabelle; Starkel, Peter; Moreno, Christophe; Nevens, Frederik; Vanwolleghem, Thomas | Journal Contribution | M |
| 80 | 2017 | The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience | BIELEN, Rob; Moreno, C.; Van Vlierberghe, H.; Bourgeois, S.; Mulkay, J. -P.; Vanwolleghem, T.; Verlinden, W.; Brixco, C.; Decaestecker, J.; de Galocsy, C.; Janssens, F.; Van Overbeke, L.; Van Steenkiste, C.; D'Heygere, F.; Cool, M.; Wuyckens, K.; Nevens, F.; ROBAEYS, Geert | Journal Contribution | A1 |
Loading...
5
0
5
0
false